Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104

Stock Information for Acasti Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Acasti Pharma Inc.

Grace Therapeutics to Participate in Upcoming Investor Events January 2025
Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Acasti to Present at the Life Sciences Investor Forum
Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.